2020-2025 Global Benign Prostatic Hyperplasia Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
This report elaborates the market size, market characteristics, and market growth of the Benign Prostatic Hyperplasia industry, and breaks down according to the type, application, and consumption area of Benign Prostatic Hyperplasia. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Benign Prostatic Hyperplasia in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Benign Prostatic Hyperplasia market covered in Chapter 13:
Astellas Pharma Inc.
GlaxoSmithKline PLC
Eli Lilly and Company
Allergan PLC
Sophiris Bio Corp.
Teva Pharmaceutical Industries Limited
Boehringer Ingelheim
Nymox Pharmaceutical Corporation
Pfizer Inc.
Sanofi
In Chapter 6, on the basis of types, the Benign Prostatic Hyperplasia market from 2015 to 2025 is primarily split into:
Alpha-Blockers
5- Alpha-Reductase Inhibitors (5-Aris)
Alpha-Adrenergic Blockers
Phosphodiesterase-5 Enzyme Inhibitors
Other
In Chapter 7, on the basis of applications, the Benign Prostatic Hyperplasia market from 2015 to 2025 covers:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Benign Prostatic Hyperplasia in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Benign Prostatic Hyperplasia market covered in Chapter 13:
Astellas Pharma Inc.
GlaxoSmithKline PLC
Eli Lilly and Company
Allergan PLC
Sophiris Bio Corp.
Teva Pharmaceutical Industries Limited
Boehringer Ingelheim
Nymox Pharmaceutical Corporation
Pfizer Inc.
Sanofi
In Chapter 6, on the basis of types, the Benign Prostatic Hyperplasia market from 2015 to 2025 is primarily split into:
Alpha-Blockers
5- Alpha-Reductase Inhibitors (5-Aris)
Alpha-Adrenergic Blockers
Phosphodiesterase-5 Enzyme Inhibitors
Other
In Chapter 7, on the basis of applications, the Benign Prostatic Hyperplasia market from 2015 to 2025 covers:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 BENIGN PROSTATIC HYPERPLASIA MARKET - RESEARCH SCOPE
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 BENIGN PROSTATIC HYPERPLASIA MARKET - RESEARCH METHODOLOGY
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 BENIGN PROSTATIC HYPERPLASIA MARKET FORCES
3.1 Global Benign Prostatic Hyperplasia Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 BENIGN PROSTATIC HYPERPLASIA MARKET - BY GEOGRAPHY
4.1 Global Benign Prostatic Hyperplasia Market Value and Market Share by Regions
4.1.1 Global Benign Prostatic Hyperplasia Value ($) by Region (2015-2020)
4.1.2 Global Benign Prostatic Hyperplasia Value Market Share by Regions (2015-2020)
4.2 Global Benign Prostatic Hyperplasia Market Production and Market Share by Major Countries
4.2.1 Global Benign Prostatic Hyperplasia Production by Major Countries (2015-2020)
4.2.2 Global Benign Prostatic Hyperplasia Production Market Share by Major Countries (2015-2020)
4.3 Global Benign Prostatic Hyperplasia Market Consumption and Market Share by Regions
4.3.1 Global Benign Prostatic Hyperplasia Consumption by Regions (2015-2020)
4.3.2 Global Benign Prostatic Hyperplasia Consumption Market Share by Regions (2015-2020)
5 BENIGN PROSTATIC HYPERPLASIA MARKET - BY TRADE STATISTICS
5.1 Global Benign Prostatic Hyperplasia Export and Import
5.2 United States Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.3 Europe Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.4 China Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.5 Japan Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.6 India Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.7 ...
6 BENIGN PROSTATIC HYPERPLASIA MARKET - BY TYPE
6.1 Global Benign Prostatic Hyperplasia Production and Market Share by Types (2015-2020)
6.1.1 Global Benign Prostatic Hyperplasia Production by Types (2015-2020)
6.1.2 Global Benign Prostatic Hyperplasia Production Market Share by Types (2015-2020)
6.2 Global Benign Prostatic Hyperplasia Value and Market Share by Types (2015-2020)
6.2.1 Global Benign Prostatic Hyperplasia Value by Types (2015-2020)
6.2.2 Global Benign Prostatic Hyperplasia Value Market Share by Types (2015-2020)
6.3 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Alpha-Blockers (2015-2020)
6.4 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of 5- Alpha-Reductase Inhibitors (5-Aris) (2015-2020)
6.5 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Alpha-Adrenergic Blockers (2015-2020)
6.6 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Phosphodiesterase-5 Enzyme Inhibitors (2015-2020)
6.7 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Other (2015-2020)
7 BENIGN PROSTATIC HYPERPLASIA MARKET - BY APPLICATION
7.1 Global Benign Prostatic Hyperplasia Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Benign Prostatic Hyperplasia Consumption by Applications (2015-2020)
7.1.2 Global Benign Prostatic Hyperplasia Consumption Market Share by Applications (2015-2020)
7.2 Global Benign Prostatic Hyperplasia Consumption and Growth Rate of Hospital Pharmacies (2015-2020)
7.3 Global Benign Prostatic Hyperplasia Consumption and Growth Rate of Retail Pharmacies (2015-2020)
7.4 Global Benign Prostatic Hyperplasia Consumption and Growth Rate of Online Pharmacies (2015-2020)
8 NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA MARKET
8.1 North America Benign Prostatic Hyperplasia Market Size
8.2 United States Benign Prostatic Hyperplasia Market Size
8.3 Canada Benign Prostatic Hyperplasia Market Size
8.4 Mexico Benign Prostatic Hyperplasia Market Size
8.5 The Influence of COVID-19 on North America Market
9 EUROPE BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
9.1 Europe Benign Prostatic Hyperplasia Market Size
9.2 Germany Benign Prostatic Hyperplasia Market Size
9.3 United Kingdom Benign Prostatic Hyperplasia Market Size
9.4 France Benign Prostatic Hyperplasia Market Size
9.5 Italy Benign Prostatic Hyperplasia Market Size
9.6 Spain Benign Prostatic Hyperplasia Market Size
9.7 The Influence of COVID-19 on Europe Market
10 ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
10.1 Asia-Pacific Benign Prostatic Hyperplasia Market Size
10.2 China Benign Prostatic Hyperplasia Market Size
10.3 Japan Benign Prostatic Hyperplasia Market Size
10.4 South Korea Benign Prostatic Hyperplasia Market Size
10.5 Southeast Asia Benign Prostatic Hyperplasia Market Size
10.6 India Benign Prostatic Hyperplasia Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
11.1 Middle East and Africa Benign Prostatic Hyperplasia Market Size
11.2 Saudi Arabia Benign Prostatic Hyperplasia Market Size
11.3 UAE Benign Prostatic Hyperplasia Market Size
11.4 South Africa Benign Prostatic Hyperplasia Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 SOUTH AMERICA BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
12.1 South America Benign Prostatic Hyperplasia Market Size
12.2 Brazil Benign Prostatic Hyperplasia Market Size
12.3 The Influence of COVID-19 on South America Market
13 COMPANY PROFILES
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Basic Information
13.1.2 Astellas Pharma Inc. Product Profiles, Application and Specification
13.1.3 Astellas Pharma Inc. Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.2 GlaxoSmithKline PLC
13.2.1 GlaxoSmithKline PLC Basic Information
13.2.2 GlaxoSmithKline PLC Product Profiles, Application and Specification
13.2.3 GlaxoSmithKline PLC Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Basic Information
13.3.2 Eli Lilly and Company Product Profiles, Application and Specification
13.3.3 Eli Lilly and Company Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.4 Allergan PLC
13.4.1 Allergan PLC Basic Information
13.4.2 Allergan PLC Product Profiles, Application and Specification
13.4.3 Allergan PLC Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.5 Sophiris Bio Corp.
13.5.1 Sophiris Bio Corp. Basic Information
13.5.2 Sophiris Bio Corp. Product Profiles, Application and Specification
13.5.3 Sophiris Bio Corp. Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.6 Teva Pharmaceutical Industries Limited
13.6.1 Teva Pharmaceutical Industries Limited Basic Information
13.6.2 Teva Pharmaceutical Industries Limited Product Profiles, Application and Specification
13.6.3 Teva Pharmaceutical Industries Limited Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Basic Information
13.7.2 Boehringer Ingelheim Product Profiles, Application and Specification
13.7.3 Boehringer Ingelheim Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.8 Nymox Pharmaceutical Corporation
13.8.1 Nymox Pharmaceutical Corporation Basic Information
13.8.2 Nymox Pharmaceutical Corporation Product Profiles, Application and Specification
13.8.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Basic Information
13.9.2 Pfizer Inc. Product Profiles, Application and Specification
13.9.3 Pfizer Inc. Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.10 Sanofi
13.10.1 Sanofi Basic Information
13.10.2 Sanofi Product Profiles, Application and Specification
13.10.3 Sanofi Benign Prostatic Hyperplasia Market Performance (2015-2020)
14 MARKET FORECAST - BY REGIONS
14.1 North America Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.2 Europe Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.3 Asia-Pacific Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.4 Middle East and Africa Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.5 South America Benign Prostatic Hyperplasia Market Forecast (2020-2025)
15 MARKET FORECAST - BY TYPE AND APPLICATIONS
15.1 Global Benign Prostatic Hyperplasia Market Forecast by Types (2020-2025)
15.1.1 Global Benign Prostatic Hyperplasia Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Benign Prostatic Hyperplasia Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Benign Prostatic Hyperplasia Market Forecast by Applications (2020-2025)
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 BENIGN PROSTATIC HYPERPLASIA MARKET - RESEARCH METHODOLOGY
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 BENIGN PROSTATIC HYPERPLASIA MARKET FORCES
3.1 Global Benign Prostatic Hyperplasia Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 BENIGN PROSTATIC HYPERPLASIA MARKET - BY GEOGRAPHY
4.1 Global Benign Prostatic Hyperplasia Market Value and Market Share by Regions
4.1.1 Global Benign Prostatic Hyperplasia Value ($) by Region (2015-2020)
4.1.2 Global Benign Prostatic Hyperplasia Value Market Share by Regions (2015-2020)
4.2 Global Benign Prostatic Hyperplasia Market Production and Market Share by Major Countries
4.2.1 Global Benign Prostatic Hyperplasia Production by Major Countries (2015-2020)
4.2.2 Global Benign Prostatic Hyperplasia Production Market Share by Major Countries (2015-2020)
4.3 Global Benign Prostatic Hyperplasia Market Consumption and Market Share by Regions
4.3.1 Global Benign Prostatic Hyperplasia Consumption by Regions (2015-2020)
4.3.2 Global Benign Prostatic Hyperplasia Consumption Market Share by Regions (2015-2020)
5 BENIGN PROSTATIC HYPERPLASIA MARKET - BY TRADE STATISTICS
5.1 Global Benign Prostatic Hyperplasia Export and Import
5.2 United States Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.3 Europe Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.4 China Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.5 Japan Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.6 India Benign Prostatic Hyperplasia Export and Import (2015-2020)
5.7 ...
6 BENIGN PROSTATIC HYPERPLASIA MARKET - BY TYPE
6.1 Global Benign Prostatic Hyperplasia Production and Market Share by Types (2015-2020)
6.1.1 Global Benign Prostatic Hyperplasia Production by Types (2015-2020)
6.1.2 Global Benign Prostatic Hyperplasia Production Market Share by Types (2015-2020)
6.2 Global Benign Prostatic Hyperplasia Value and Market Share by Types (2015-2020)
6.2.1 Global Benign Prostatic Hyperplasia Value by Types (2015-2020)
6.2.2 Global Benign Prostatic Hyperplasia Value Market Share by Types (2015-2020)
6.3 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Alpha-Blockers (2015-2020)
6.4 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of 5- Alpha-Reductase Inhibitors (5-Aris) (2015-2020)
6.5 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Alpha-Adrenergic Blockers (2015-2020)
6.6 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Phosphodiesterase-5 Enzyme Inhibitors (2015-2020)
6.7 Global Benign Prostatic Hyperplasia Production, Price and Growth Rate of Other (2015-2020)
7 BENIGN PROSTATIC HYPERPLASIA MARKET - BY APPLICATION
7.1 Global Benign Prostatic Hyperplasia Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Benign Prostatic Hyperplasia Consumption by Applications (2015-2020)
7.1.2 Global Benign Prostatic Hyperplasia Consumption Market Share by Applications (2015-2020)
7.2 Global Benign Prostatic Hyperplasia Consumption and Growth Rate of Hospital Pharmacies (2015-2020)
7.3 Global Benign Prostatic Hyperplasia Consumption and Growth Rate of Retail Pharmacies (2015-2020)
7.4 Global Benign Prostatic Hyperplasia Consumption and Growth Rate of Online Pharmacies (2015-2020)
8 NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA MARKET
8.1 North America Benign Prostatic Hyperplasia Market Size
8.2 United States Benign Prostatic Hyperplasia Market Size
8.3 Canada Benign Prostatic Hyperplasia Market Size
8.4 Mexico Benign Prostatic Hyperplasia Market Size
8.5 The Influence of COVID-19 on North America Market
9 EUROPE BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
9.1 Europe Benign Prostatic Hyperplasia Market Size
9.2 Germany Benign Prostatic Hyperplasia Market Size
9.3 United Kingdom Benign Prostatic Hyperplasia Market Size
9.4 France Benign Prostatic Hyperplasia Market Size
9.5 Italy Benign Prostatic Hyperplasia Market Size
9.6 Spain Benign Prostatic Hyperplasia Market Size
9.7 The Influence of COVID-19 on Europe Market
10 ASIA-PACIFIC BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
10.1 Asia-Pacific Benign Prostatic Hyperplasia Market Size
10.2 China Benign Prostatic Hyperplasia Market Size
10.3 Japan Benign Prostatic Hyperplasia Market Size
10.4 South Korea Benign Prostatic Hyperplasia Market Size
10.5 Southeast Asia Benign Prostatic Hyperplasia Market Size
10.6 India Benign Prostatic Hyperplasia Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 MIDDLE EAST AND AFRICA BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
11.1 Middle East and Africa Benign Prostatic Hyperplasia Market Size
11.2 Saudi Arabia Benign Prostatic Hyperplasia Market Size
11.3 UAE Benign Prostatic Hyperplasia Market Size
11.4 South Africa Benign Prostatic Hyperplasia Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 SOUTH AMERICA BENIGN PROSTATIC HYPERPLASIA MARKET ANALYSIS
12.1 South America Benign Prostatic Hyperplasia Market Size
12.2 Brazil Benign Prostatic Hyperplasia Market Size
12.3 The Influence of COVID-19 on South America Market
13 COMPANY PROFILES
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Basic Information
13.1.2 Astellas Pharma Inc. Product Profiles, Application and Specification
13.1.3 Astellas Pharma Inc. Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.2 GlaxoSmithKline PLC
13.2.1 GlaxoSmithKline PLC Basic Information
13.2.2 GlaxoSmithKline PLC Product Profiles, Application and Specification
13.2.3 GlaxoSmithKline PLC Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Basic Information
13.3.2 Eli Lilly and Company Product Profiles, Application and Specification
13.3.3 Eli Lilly and Company Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.4 Allergan PLC
13.4.1 Allergan PLC Basic Information
13.4.2 Allergan PLC Product Profiles, Application and Specification
13.4.3 Allergan PLC Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.5 Sophiris Bio Corp.
13.5.1 Sophiris Bio Corp. Basic Information
13.5.2 Sophiris Bio Corp. Product Profiles, Application and Specification
13.5.3 Sophiris Bio Corp. Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.6 Teva Pharmaceutical Industries Limited
13.6.1 Teva Pharmaceutical Industries Limited Basic Information
13.6.2 Teva Pharmaceutical Industries Limited Product Profiles, Application and Specification
13.6.3 Teva Pharmaceutical Industries Limited Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Basic Information
13.7.2 Boehringer Ingelheim Product Profiles, Application and Specification
13.7.3 Boehringer Ingelheim Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.8 Nymox Pharmaceutical Corporation
13.8.1 Nymox Pharmaceutical Corporation Basic Information
13.8.2 Nymox Pharmaceutical Corporation Product Profiles, Application and Specification
13.8.3 Nymox Pharmaceutical Corporation Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.9 Pfizer Inc.
13.9.1 Pfizer Inc. Basic Information
13.9.2 Pfizer Inc. Product Profiles, Application and Specification
13.9.3 Pfizer Inc. Benign Prostatic Hyperplasia Market Performance (2015-2020)
13.10 Sanofi
13.10.1 Sanofi Basic Information
13.10.2 Sanofi Product Profiles, Application and Specification
13.10.3 Sanofi Benign Prostatic Hyperplasia Market Performance (2015-2020)
14 MARKET FORECAST - BY REGIONS
14.1 North America Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.2 Europe Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.3 Asia-Pacific Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.4 Middle East and Africa Benign Prostatic Hyperplasia Market Forecast (2020-2025)
14.5 South America Benign Prostatic Hyperplasia Market Forecast (2020-2025)
15 MARKET FORECAST - BY TYPE AND APPLICATIONS
15.1 Global Benign Prostatic Hyperplasia Market Forecast by Types (2020-2025)
15.1.1 Global Benign Prostatic Hyperplasia Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Benign Prostatic Hyperplasia Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Benign Prostatic Hyperplasia Market Forecast by Applications (2020-2025)
LIST OF TABLES AND FIGURES
Figure Benign Prostatic Hyperplasia Picture
Table Benign Prostatic Hyperplasia Key Market Segments
Figure Study and Forecasting Years
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Benign Prostatic Hyperplasia Value ($) and Growth Rate (2015-2020)
Table Global Benign Prostatic Hyperplasia Value ($) by Countries (2015-2020)
Table Global Benign Prostatic Hyperplasia Value Market Share by Regions (2015-2020)
Figure Global Benign Prostatic Hyperplasia Value Market Share by Regions in 2019
Figure Global Benign Prostatic Hyperplasia Production and Growth Rate (2015-2020)
Table Global Benign Prostatic Hyperplasia Production by Major Countries (2015-2020)
Table Global Benign Prostatic Hyperplasia Production Market Share by Major Countries (2015-2020)
Figure Global Benign Prostatic Hyperplasia Production Market Share by Regions in 2019
Figure Global Benign Prostatic Hyperplasia Consumption and Growth Rate (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption by Regions (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption Market Share by Regions (2015-2020)
Figure Global Benign Prostatic Hyperplasia Consumption Market Share by Regions in 2019
Table Global Benign Prostatic Hyperplasia Export Top 3 Country 2019
Table Global Benign Prostatic Hyperplasia Import Top 3 Country 2019
Table United States Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table Europe Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table China Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table Japan Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table India Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table Global Benign Prostatic Hyperplasia Production by Types (2015-2020)
Table Global Benign Prostatic Hyperplasia Production Market Share by Types (2015-2020)
Figure Global Benign Prostatic Hyperplasia Production Share by Type (2015-2020)
Table Global Benign Prostatic Hyperplasia Value by Types (2015-2020)
Table Global Benign Prostatic Hyperplasia Value Market Share by Types (2015-2020)
Figure Global Benign Prostatic Hyperplasia Value Share by Type (2015-2020)
Figure Global Alpha-Blockers Production and Growth Rate (2015-2020)
Figure Global Alpha-Blockers Price (2015-2020)
Figure Global 5- Alpha-Reductase Inhibitors (5-Aris) Production and Growth Rate (2015-2020)
Figure Global 5- Alpha-Reductase Inhibitors (5-Aris) Price (2015-2020)
Figure Global Alpha-Adrenergic Blockers Production and Growth Rate (2015-2020)
Figure Global Alpha-Adrenergic Blockers Price (2015-2020)
Figure Global Phosphodiesterase-5 Enzyme Inhibitors Production and Growth Rate (2015-2020)
Figure Global Phosphodiesterase-5 Enzyme Inhibitors Price (2015-2020)
Figure Global Other Production and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption by Applications (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption Market Share by Applications (2015-2020)
Figure Global Benign Prostatic Hyperplasia Consumption Share by Application (2015-2020)
Figure Global Hospital Pharmacies Consumption and Growth Rate (2015-2020)
Figure Global Retail Pharmacies Consumption and Growth Rate (2015-2020)
Figure Global Online Pharmacies Consumption and Growth Rate (2015-2020)
Figure North America Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table North America Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table North America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure North America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure United States Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Canada Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Mexico Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Europe Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table Europe Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Europe Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Germany Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure France Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Italy Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Spain Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table Asia-Pacific Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure China Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Japan Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure South Korea Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure India Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table Middle East and Africa Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure UAE Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure South Africa Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure South America Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table South America Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table South America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure South America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Brazil Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Astellas Pharma Inc. Company Profile
Table Astellas Pharma Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Astellas Pharma Inc. Production and Growth Rate
Figure Astellas Pharma Inc. Value ($) Market Share 2015-2020
Table GlaxoSmithKline PLC Company Profile
Table GlaxoSmithKline PLC Production, Value, Price, Gross Margin 2015-2020
Figure GlaxoSmithKline PLC Production and Growth Rate
Figure GlaxoSmithKline PLC Value ($) Market Share 2015-2020
Table Eli Lilly and Company Company Profile
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2015-2020
Table Allergan PLC Company Profile
Table Allergan PLC Production, Value, Price, Gross Margin 2015-2020
Figure Allergan PLC Production and Growth Rate
Figure Allergan PLC Value ($) Market Share 2015-2020
Table Sophiris Bio Corp. Company Profile
Table Sophiris Bio Corp. Production, Value, Price, Gross Margin 2015-2020
Figure Sophiris Bio Corp. Production and Growth Rate
Figure Sophiris Bio Corp. Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Limited Company Profile
Table Teva Pharmaceutical Industries Limited Production, Value, Price, Gross Margin 2015-2020
Figure Teva Pharmaceutical Industries Limited Production and Growth Rate
Figure Teva Pharmaceutical Industries Limited Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Nymox Pharmaceutical Corporation Company Profile
Table Nymox Pharmaceutical Corporation Production, Value, Price, Gross Margin 2015-2020
Figure Nymox Pharmaceutical Corporation Production and Growth Rate
Figure Nymox Pharmaceutical Corporation Value ($) Market Share 2015-2020
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Sanofi Company Profile
Table Sanofi Production, Value, Price, Gross Margin 2015-2020
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Production by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Production Share by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Value ($) by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Value Share by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Consumption by Applications (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Consumption Share by Applications (2020-2025)
Figure Benign Prostatic Hyperplasia Picture
Table Benign Prostatic Hyperplasia Key Market Segments
Figure Study and Forecasting Years
Figure Global Benign Prostatic Hyperplasia Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Benign Prostatic Hyperplasia Value ($) and Growth Rate (2015-2020)
Table Global Benign Prostatic Hyperplasia Value ($) by Countries (2015-2020)
Table Global Benign Prostatic Hyperplasia Value Market Share by Regions (2015-2020)
Figure Global Benign Prostatic Hyperplasia Value Market Share by Regions in 2019
Figure Global Benign Prostatic Hyperplasia Production and Growth Rate (2015-2020)
Table Global Benign Prostatic Hyperplasia Production by Major Countries (2015-2020)
Table Global Benign Prostatic Hyperplasia Production Market Share by Major Countries (2015-2020)
Figure Global Benign Prostatic Hyperplasia Production Market Share by Regions in 2019
Figure Global Benign Prostatic Hyperplasia Consumption and Growth Rate (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption by Regions (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption Market Share by Regions (2015-2020)
Figure Global Benign Prostatic Hyperplasia Consumption Market Share by Regions in 2019
Table Global Benign Prostatic Hyperplasia Export Top 3 Country 2019
Table Global Benign Prostatic Hyperplasia Import Top 3 Country 2019
Table United States Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table Europe Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table China Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table Japan Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table India Benign Prostatic Hyperplasia Export and Import (2015-2020)
Table Global Benign Prostatic Hyperplasia Production by Types (2015-2020)
Table Global Benign Prostatic Hyperplasia Production Market Share by Types (2015-2020)
Figure Global Benign Prostatic Hyperplasia Production Share by Type (2015-2020)
Table Global Benign Prostatic Hyperplasia Value by Types (2015-2020)
Table Global Benign Prostatic Hyperplasia Value Market Share by Types (2015-2020)
Figure Global Benign Prostatic Hyperplasia Value Share by Type (2015-2020)
Figure Global Alpha-Blockers Production and Growth Rate (2015-2020)
Figure Global Alpha-Blockers Price (2015-2020)
Figure Global 5- Alpha-Reductase Inhibitors (5-Aris) Production and Growth Rate (2015-2020)
Figure Global 5- Alpha-Reductase Inhibitors (5-Aris) Price (2015-2020)
Figure Global Alpha-Adrenergic Blockers Production and Growth Rate (2015-2020)
Figure Global Alpha-Adrenergic Blockers Price (2015-2020)
Figure Global Phosphodiesterase-5 Enzyme Inhibitors Production and Growth Rate (2015-2020)
Figure Global Phosphodiesterase-5 Enzyme Inhibitors Price (2015-2020)
Figure Global Other Production and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption by Applications (2015-2020)
Table Global Benign Prostatic Hyperplasia Consumption Market Share by Applications (2015-2020)
Figure Global Benign Prostatic Hyperplasia Consumption Share by Application (2015-2020)
Figure Global Hospital Pharmacies Consumption and Growth Rate (2015-2020)
Figure Global Retail Pharmacies Consumption and Growth Rate (2015-2020)
Figure Global Online Pharmacies Consumption and Growth Rate (2015-2020)
Figure North America Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table North America Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table North America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure North America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure United States Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Canada Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Mexico Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Europe Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table Europe Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Europe Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Germany Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure France Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Italy Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Spain Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table Asia-Pacific Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure China Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Japan Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure South Korea Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure India Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table Middle East and Africa Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure UAE Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure South Africa Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Figure South America Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table South America Benign Prostatic Hyperplasia Consumption by Countries (2015-2020)
Table South America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure South America Benign Prostatic Hyperplasia Consumption Market Share by Countries (2015-2020)
Figure Brazil Benign Prostatic Hyperplasia Market Consumption and Growth Rate (2015-2020)
Table Astellas Pharma Inc. Company Profile
Table Astellas Pharma Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Astellas Pharma Inc. Production and Growth Rate
Figure Astellas Pharma Inc. Value ($) Market Share 2015-2020
Table GlaxoSmithKline PLC Company Profile
Table GlaxoSmithKline PLC Production, Value, Price, Gross Margin 2015-2020
Figure GlaxoSmithKline PLC Production and Growth Rate
Figure GlaxoSmithKline PLC Value ($) Market Share 2015-2020
Table Eli Lilly and Company Company Profile
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2015-2020
Table Allergan PLC Company Profile
Table Allergan PLC Production, Value, Price, Gross Margin 2015-2020
Figure Allergan PLC Production and Growth Rate
Figure Allergan PLC Value ($) Market Share 2015-2020
Table Sophiris Bio Corp. Company Profile
Table Sophiris Bio Corp. Production, Value, Price, Gross Margin 2015-2020
Figure Sophiris Bio Corp. Production and Growth Rate
Figure Sophiris Bio Corp. Value ($) Market Share 2015-2020
Table Teva Pharmaceutical Industries Limited Company Profile
Table Teva Pharmaceutical Industries Limited Production, Value, Price, Gross Margin 2015-2020
Figure Teva Pharmaceutical Industries Limited Production and Growth Rate
Figure Teva Pharmaceutical Industries Limited Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Company Profile
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Nymox Pharmaceutical Corporation Company Profile
Table Nymox Pharmaceutical Corporation Production, Value, Price, Gross Margin 2015-2020
Figure Nymox Pharmaceutical Corporation Production and Growth Rate
Figure Nymox Pharmaceutical Corporation Value ($) Market Share 2015-2020
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Sanofi Company Profile
Table Sanofi Production, Value, Price, Gross Margin 2015-2020
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Production by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Production Share by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Value ($) by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Value Share by Types (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Consumption by Applications (2020-2025)
Table Global Benign Prostatic Hyperplasia Market Forecast Consumption Share by Applications (2020-2025)
